Nuria Massana-Martinell

Mrs. Nuria Massana-Martinell

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
MPMarina Parra-Robert
Marina Parra-Robert
ECEudald Casals
Eudald Casals
NMNuria Massana-Martinell
Nuria Massana-Martinell
MZMuling Zeng
Muling Zeng
MPMeritxell Perramón
Meritxell Perramón
GCGregori Casals
Gregori Casals
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic accumulation of lipids. Antisteatotic effects of cerium oxide nanoparticles (CeO2NPs) have recently been shown in animal models of liver disease. However, it is unclear whether the activity of CeO2NPs is related solely to the decrease in oxidative stress or, in addition, they directly decrease liver fatty acid accumulation. To address this question, in this work, we used an in vitro model of hepatocellular steatosis, exposing HepG2 cells to oleic and palmitic acid. Cell uptake of CeO2NPs and their effect on oxidative stress and viability of hepatic cells cultured with H2O2 were also evaluated. Results show that CeO2NPs were uptaken by HepG2 cells and reduced oxidative stress and improved cell viability. Treatment with oleic and palmitic acid increased lipogenesis and the content of different fatty acids. CeO2NPs reduced palmitic and stearic acid and most fatty acids consisting of more than 18 carbon atoms. These effects were associated with significant changes in elongase and desaturase activity. In conclusion, CeO2NPs directly protected HepG2 cells from cell injury in oxidative stress conditions and reduced fatty acid content in steatotic conditions by inducing specific changes in fatty acid metabolism, thus showing potential in the treatment of NAFLD.

1 April 2018 in Journal of Chromatography B
Verified
Journal Article
Closed access
EFEsther Fernández-Galán
Esther Fernández-Galán
NMNuria Massana-Martinell
Nuria Massana-Martinell
MPMarina Parra-Robert
Marina Parra-Robert
SHSusana Hidalgo
Susana Hidalgo
GCGregori Casals
Gregori Casals
WJWladimiro Jiménez
Wladimiro Jiménez

4 December 2020 in medRxiv
Verified
Preprint
Open access
PDF file
JGJudith Grau-Expósito
Judith Grau-Expósito
NSNerea Sánchez-Gaona
Nerea Sánchez-Gaona
NMNuria Massana-Martinell
Nuria Massana-Martinell
MSMarina Suppi
Marina Suppi
AAAntonio Astorga-Gamaza
Antonio Astorga-Gamaza
MGMeritxell Genescà
Meritxell Genescà
SUMMARY: Considering that SARS-CoV-2 interacts with the host at the respiratory tract mucosal interface, T cells strategically placed within these surfaces, namely resident memory T cells, will be essential to limit viral spread and disease. Importantly, these cells are mostly non-recirculating, which reduces the window of opportunity to examine circulating lymphocytes in blood as they home to the lung parenchyma. Here, we demonstrate that viral specific T cells can migrate and establish in the lung as resident memory T cells remaining detectable up to 10 months after initial infection. Moreover, focusing on the acute phase of the infection, we identified virus-specific T cell responses in blood with functional, migratory and apoptotic patterns modulated by viral proteins and associated with clinical outcome. Our study highlights IL-10 secretion by virus-specific T cells associated to a better outcome and the persistence of resident memory T cells as key players for future protection against SARS-CoV-2 infection.